Clinical Trial Update: Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravenous iron for iron deficiency in patients with heart failure with preserved ejection fraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Iron Deficiency

Drugs mentioned

• Intravenous iron

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Iron-deficiency, Heart Failure | Phase 4 | Status: COMPLETED